According to the research report, the global market for Lacosamide Tablets should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Lacosamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Lacosamide Tablets market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, 50 mg/tablet segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Adults has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Lacosamide Tablets include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories, Alembic Pharma, Glenmark, Accord Healthcare, Mylan and Sun PharmaApotex, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
This report aims to provide a comprehensive study of the global market for Lacosamide Tablets. Key Takeaways and Highlights
(1) Global Lacosamide Tablets market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Lacosamide Tablets market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Lacosamide Tablets market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Lacosamide Tablets segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Lacosamide Tablets segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Lacosamide Tablets, capacity, production and trends.
(7) Lacosamide Tablets industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Application-Based Segmentation: Unlocking Market Opportunities
Adults
Children
In the Spotlight: A Closer Look at Market Players
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
1 Market Overview
1.1 Lacosamide Tablets Definition
1.2 Global Lacosamide Tablets Market Size and Forecast
1.2.1 By Revenue, Global Lacosamide Tablets Market Size, 2018-2029
1.2.2 By Sales Volume, Global Lacosamide Tablets Market Size, 2018-2029
1.2.3 Global Lacosamide Tablets Price Trend, 2018-2029
1.3 China Lacosamide Tablets Market Size and Forecast
1.3.1 By Revenue, China Lacosamide Tablets Market Size, 2018-2029
1.3.2 By Sales Volume, China Lacosamide Tablets Market Size, 2018-2029
1.3.3 China Lacosamide Tablets Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Lacosamide Tablets Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Lacosamide Tablets Share in Global Market, 2018-2029
1.4.3 Lacosamide Tablets Market Size: China VS Global, 2018-2029
1.5 Lacosamide Tablets Market Dynamics
1.5.1 Lacosamide Tablets Market Drivers
1.5.2 Lacosamide Tablets Market Restraints
1.5.3 Lacosamide Tablets Industry Trends
1.5.4 Lacosamide Tablets Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Lacosamide Tablets Revenue by Company, 2018-2023
2.2 Global Lacosamide Tablets Sales Volume by Company, 2018-2023
2.3 Global Lacosamide Tablets Price by Company, 2018-2023
2.4 Global Lacosamide Tablets Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Lacosamide Tablets Concentration Ratio
2.6 Global Lacosamide Tablets Mergers & Acquisitions, Expansion Plans
2.7 Global Lacosamide Tablets Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Lacosamide Tablets Revenue by Company, 2018-2023
3.2 China Lacosamide Tablets Sales Volume by Company, 2018-2023
3.3 China Lacosamide Tablets Lacosamide Tablets Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Lacosamide Tablets Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Lacosamide Tablets Domestic VS Export
3.6 China Market, Lacosamide Tablets Import & Export
3.6.1 China Market, Lacosamide Tablets Import & Export, 2018-2029
3.6.2 China Lacosamide Tablets Import & Export Trends
3.6.3 Main Sources of China Lacosamide Tablets Import
3.6.4 Export Destination of China Lacosamide Tablets
4 Lacosamide Tablets Production by Region
4.1 Global Lacosamide Tablets Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Lacosamide Tablets Manufacturers
4.3 Global Major Manufacturers, Lacosamide Tablets Capacity Expansion and Future Plans
4.4 Global Lacosamide Tablets Capacity by Region
4.5 Global Lacosamide Tablets Production by Region
4.5.1 Global Lacosamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Lacosamide Tablets Production by Region, 2018-2023
4.5.3 Global Lacosamide Tablets Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Lacosamide Tablets Industry Chain
5.2 Lacosamide Tablets Upstream Analysis
5.2.1 Lacosamide Tablets Core Raw Materials
5.2.2 Main Manufacturers of Lacosamide Tablets Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lacosamide Tablets Production Mode
5.6 Lacosamide Tablets Procurement Model
5.7 Lacosamide Tablets Industry Sales Model and Sales Channels
5.7.1 Lacosamide Tablets Sales Model
5.7.2 Lacosamide Tablets Typical Distributors
6 Sights by Type
6.1 Lacosamide Tablets Classification
6.1.1 50 mg/tablet
6.1.2 100 mg/tablet
6.1.3 150 mg/tablet
6.1.4 200 mg/tablet
6.2 By Type, Global Lacosamide Tablets Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Lacosamide Tablets Revenue, 2018-2029
6.4 By Type, Global Lacosamide Tablets Sales Volume, 2018-2029
6.5 By Type, Global Lacosamide Tablets Price, 2018-2029
7 Sights by Application
7.1 Lacosamide Tablets Segment by Application
7.1.1 Adults
7.1.2 Children
7.2 By Application, Global Lacosamide Tablets Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Lacosamide Tablets Revenue, 2018-2029
7.4 By Application, Global Lacosamide Tablets Sales Volume, 2018-2029
7.5 By Application, Global Lacosamide Tablets Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Lacosamide Tablets Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Lacosamide Tablets Revenue, 2018-2029
8.3 By Region, Global Lacosamide Tablets Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Lacosamide Tablets Market Size Market Share
8.5 Europe
8.5.1 Europe Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Lacosamide Tablets Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Lacosamide Tablets Market Size Market Share
8.7 South America
8.7.1 South America Lacosamide Tablets Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Lacosamide Tablets Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Lacosamide Tablets Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Lacosamide Tablets Revenue, 2018-2029
9.3 By Country, Global Lacosamide Tablets Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Lacosamide Tablets Market Size, 2018-2029
9.4.2 By Company, U.S. Lacosamide Tablets Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Lacosamide Tablets Market Size, 2018-2029
9.5.2 By Company, Europe Lacosamide Tablets Sales Volume Market Share, 2022
9.5.3 By Type, Europe Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Lacosamide Tablets Market Size, 2018-2029
9.6.2 By Company, China Lacosamide Tablets Sales Volume Market Share, 2022
9.6.3 By Type, China Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Lacosamide Tablets Market Size, 2018-2029
9.7.2 By Company, Japan Lacosamide Tablets Sales Volume Market Share, 2022
9.7.3 By Type, Japan Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Lacosamide Tablets Market Size, 2018-2029
9.8.2 By Company, South Korea Lacosamide Tablets Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Lacosamide Tablets Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Lacosamide Tablets Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Lacosamide Tablets Market Size, 2018-2029
9.10.2 By Company, India Lacosamide Tablets Sales Volume Market Share, 2022
9.10.3 By Type, India Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Lacosamide Tablets Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Lacosamide Tablets Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Lacosamide Tablets Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Lacosamide Tablets Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 UCB
10.1.1 UCB Company Information, Head Office, Market Area and Industry Position
10.1.2 UCB Lacosamide Tablets Models, Specifications and Application
10.1.3 UCB Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 UCB Company Profile and Main Business
10.1.5 UCB Recent Developments
10.2 Aesica Pharmaceuticals GmbH
10.2.1 Aesica Pharmaceuticals GmbH Company Information, Head Office, Market Area and Industry Position
10.2.2 Aesica Pharmaceuticals GmbH Lacosamide Tablets Models, Specifications and Application
10.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Aesica Pharmaceuticals GmbH Company Profile and Main Business
10.2.5 Aesica Pharmaceuticals GmbH Recent Developments
10.3 Teva
10.3.1 Teva Company Information, Head Office, Market Area and Industry Position
10.3.2 Teva Lacosamide Tablets Models, Specifications and Application
10.3.3 Teva Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Teva Company Profile and Main Business
10.3.5 Teva Recent Developments
10.4 MSN Laboratories
10.4.1 MSN Laboratories Company Information, Head Office, Market Area and Industry Position
10.4.2 MSN Laboratories Lacosamide Tablets Models, Specifications and Application
10.4.3 MSN Laboratories Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 MSN Laboratories Company Profile and Main Business
10.4.5 MSN Laboratories Recent Developments
10.5 Alembic Pharma
10.5.1 Alembic Pharma Company Information, Head Office, Market Area and Industry Position
10.5.2 Alembic Pharma Lacosamide Tablets Models, Specifications and Application
10.5.3 Alembic Pharma Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Alembic Pharma Company Profile and Main Business
10.5.5 Alembic Pharma Recent Developments
10.6 Glenmark
10.6.1 Glenmark Company Information, Head Office, Market Area and Industry Position
10.6.2 Glenmark Lacosamide Tablets Models, Specifications and Application
10.6.3 Glenmark Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Glenmark Company Profile and Main Business
10.6.5 Glenmark Recent Developments
10.7 Accord Healthcare
10.7.1 Accord Healthcare Company Information, Head Office, Market Area and Industry Position
10.7.2 Accord Healthcare Lacosamide Tablets Models, Specifications and Application
10.7.3 Accord Healthcare Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Accord Healthcare Company Profile and Main Business
10.7.5 Accord Healthcare Recent Developments
10.8 Mylan
10.8.1 Mylan Company Information, Head Office, Market Area and Industry Position
10.8.2 Mylan Lacosamide Tablets Models, Specifications and Application
10.8.3 Mylan Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Mylan Company Profile and Main Business
10.8.5 Mylan Recent Developments
10.9 Sun PharmaApotex
10.9.1 Sun PharmaApotex Company Information, Head Office, Market Area and Industry Position
10.9.2 Sun PharmaApotex Lacosamide Tablets Models, Specifications and Application
10.9.3 Sun PharmaApotex Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Sun PharmaApotex Company Profile and Main Business
10.9.5 Sun PharmaApotex Recent Developments
10.10 Jiangxi Qingfeng Pharmaceutical
10.10.1 Jiangxi Qingfeng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Models, Specifications and Application
10.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Jiangxi Qingfeng Pharmaceutical Company Profile and Main Business
10.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
10.11 Beijing Sihuan Pharmaceutical
10.11.1 Beijing Sihuan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Models, Specifications and Application
10.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Beijing Sihuan Pharmaceutical Company Profile and Main Business
10.11.5 Beijing Sihuan Pharmaceutical Recent Developments
10.12 Buchang Pharmaceutical
10.12.1 Buchang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 Buchang Pharmaceutical Lacosamide Tablets Models, Specifications and Application
10.12.3 Buchang Pharmaceutical Lacosamide Tablets Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Buchang Pharmaceutical Company Profile and Main Business
10.12.5 Buchang Pharmaceutical Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Lacosamide Tablets Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Lacosamide Tablets Market Restraints
Table 3. Lacosamide Tablets Market Trends
Table 4. Lacosamide Tablets Industry Policy
Table 5. Global Lacosamide Tablets Revenue by Company, 2018-2023, US$ million
Table 6. Global Lacosamide Tablets Revenue Market Share by Company, 2018-2023
Table 7. Global Lacosamide Tablets Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Lacosamide Tablets Sales Volume Market Share by Company, 2018-2023
Table 9. Global Lacosamide Tablets Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Lacosamide Tablets Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Lacosamide Tablets Mergers & Acquisitions, Expansion Plans
Table 12. Global Lacosamide Tablets Manufacturers Product Type
Table 13. China Lacosamide Tablets Revenue by Company, 2018-2023, US$ million
Table 14. China Lacosamide Tablets Revenue Market Share by Company, 2018-2023
Table 15. China Lacosamide Tablets Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Lacosamide Tablets Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Lacosamide Tablets Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Lacosamide Tablets Import & Export Trends
Table 19. Main Sources of China Lacosamide Tablets Import
Table 20. Export Destination of China Lacosamide Tablets
Table 21. Global Headquarters and Manufacturing Base of Lacosamide Tablets Manufacturers
Table 22. Global Major Manufacturers, Lacosamide Tablets Capacity Expansion and Future Plans
Table 23. Global Lacosamide Tablets Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Lacosamide Tablets Production by Region, 2018-2023, (K Units)
Table 25. Global Lacosamide Tablets Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Lacosamide Tablets Upstream (Raw Materials)
Table 27. Global Lacosamide Tablets Typical Customers
Table 28. Lacosamide Tablets Typical Distributors
Table 29. By Type, Global Lacosamide Tablets Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Lacosamide Tablets Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Lacosamide Tablets Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Lacosamide Tablets Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Lacosamide Tablets Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Lacosamide Tablets Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Lacosamide Tablets Revenue Market Share, 2018-2029
Table 37. By Country, Global Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Lacosamide Tablets Sales Volume Market Share, 2018-2029
Table 39. UCB Company Information, Head Office, Market Area and Industry Position
Table 40. UCB Lacosamide Tablets Models, Specifications and Application
Table 41. UCB Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. UCB Company Profile and Main Business
Table 43. UCB Recent Developments
Table 44. Aesica Pharmaceuticals GmbH Company Information, Head Office, Market Area and Industry Position
Table 45. Aesica Pharmaceuticals GmbH Lacosamide Tablets Models, Specifications and Application
Table 46. Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Aesica Pharmaceuticals GmbH Company Profile and Main Business
Table 48. Aesica Pharmaceuticals GmbH Recent Developments
Table 49. Teva Company Information, Head Office, Market Area and Industry Position
Table 50. Teva Lacosamide Tablets Models, Specifications and Application
Table 51. Teva Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Teva Company Profile and Main Business
Table 53. Teva Recent Developments
Table 54. MSN Laboratories Company Information, Head Office, Market Area and Industry Position
Table 55. MSN Laboratories Lacosamide Tablets Models, Specifications and Application
Table 56. MSN Laboratories Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. MSN Laboratories Company Profile and Main Business
Table 58. MSN Laboratories Recent Developments
Table 59. Alembic Pharma Company Information, Head Office, Market Area and Industry Position
Table 60. Alembic Pharma Lacosamide Tablets Models, Specifications and Application
Table 61. Alembic Pharma Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Alembic Pharma Company Profile and Main Business
Table 63. Alembic Pharma Recent Developments
Table 64. Glenmark Company Information, Head Office, Market Area and Industry Position
Table 65. Glenmark Lacosamide Tablets Models, Specifications and Application
Table 66. Glenmark Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Glenmark Company Profile and Main Business
Table 68. Glenmark Recent Developments
Table 69. Accord Healthcare Company Information, Head Office, Market Area and Industry Position
Table 70. Accord Healthcare Lacosamide Tablets Models, Specifications and Application
Table 71. Accord Healthcare Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Accord Healthcare Company Profile and Main Business
Table 73. Accord Healthcare Recent Developments
Table 74. Mylan Company Information, Head Office, Market Area and Industry Position
Table 75. Mylan Lacosamide Tablets Models, Specifications and Application
Table 76. Mylan Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Mylan Company Profile and Main Business
Table 78. Mylan Recent Developments
Table 79. Sun PharmaApotex Company Information, Head Office, Market Area and Industry Position
Table 80. Sun PharmaApotex Lacosamide Tablets Models, Specifications and Application
Table 81. Sun PharmaApotex Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Sun PharmaApotex Company Profile and Main Business
Table 83. Sun PharmaApotex Recent Developments
Table 84. Jiangxi Qingfeng Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Models, Specifications and Application
Table 86. Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Jiangxi Qingfeng Pharmaceutical Company Profile and Main Business
Table 88. Jiangxi Qingfeng Pharmaceutical Recent Developments
Table 89. Beijing Sihuan Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 90. Beijing Sihuan Pharmaceutical Lacosamide Tablets Models, Specifications and Application
Table 91. Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Beijing Sihuan Pharmaceutical Company Profile and Main Business
Table 93. Beijing Sihuan Pharmaceutical Recent Developments
Table 94. Buchang Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. Buchang Pharmaceutical Lacosamide Tablets Models, Specifications and Application
Table 96. Buchang Pharmaceutical Lacosamide Tablets Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Buchang Pharmaceutical Company Profile and Main Business
Table 98. Buchang Pharmaceutical Recent Developments
List of Figure
Figure 1. Lacosamide Tablets Picture
Figure 2. By Revenue, Global Lacosamide Tablets Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Lacosamide Tablets Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Lacosamide Tablets Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Lacosamide Tablets Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Lacosamide Tablets Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Lacosamide Tablets Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Lacosamide Tablets Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Lacosamide Tablets Share of Global Market, 2018-2029
Figure 10. Global Lacosamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Lacosamide Tablets Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Lacosamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Lacosamide Tablets Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Lacosamide Tablets Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Lacosamide Tablets Domestic VS Export, 2022
Figure 16. Global Lacosamide Tablets Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Lacosamide Tablets Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Lacosamide Tablets Production Market Share & Forecast by Region, 2018-2029
Figure 19. Lacosamide Tablets Industry Chain
Figure 20. Lacosamide Tablets Procurement Model
Figure 21. Lacosamide Tablets Sales Model
Figure 22. Lacosamide Tablets Sales Channels, Direct Sales and Distribution
Figure 23. 50 mg/tablet
Figure 24. 100 mg/tablet
Figure 25. 150 mg/tablet
Figure 26. 200 mg/tablet
Figure 27. By Type, Global Lacosamide Tablets Revenue, 2018-2029, US$ Million
Figure 28. By Type, Global Lacosamide Tablets Revenue Market Share, 2018-2029
Figure 29. By Type, Global Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 30. By Type, Global Lacosamide Tablets Sales Volume Market Share, 2018-2029
Figure 31. By Type, Global Lacosamide Tablets Price, 2018-2029, (US$/Unit)
Figure 32. Adults
Figure 33. Children
Figure 34. By Application, Global Lacosamide Tablets Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Lacosamide Tablets Revenue Market Share, 2018-2029
Figure 36. By Application, Global Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 37. By Application, Global Lacosamide Tablets Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Lacosamide Tablets Price, 2018-2029, (US$/Unit)
Figure 39. By Region, Global Lacosamide Tablets Revenue Market Share, 2018-2029
Figure 40. By Region, Global Lacosamide Tablets Sales Volume Market Share, 2018-2029
Figure 41. North America Lacosamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Lacosamide Tablets Revenue Market Share, 2022
Figure 43. Europe Lacosamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Lacosamide Tablets Revenue Market Share, 2022
Figure 45. Asia Pacific Lacosamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Lacosamide Tablets Revenue Market Share, 2022
Figure 47. South America Lacosamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Lacosamide Tablets Revenue Market Share, 2022
Figure 49. Middle East & Africa Lacosamide Tablets Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 51. By Company, U.S. Lacosamide Tablets Market Share, 2022
Figure 52. By Type, U.S. Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, Europe Lacosamide Tablets Market Share, 2022
Figure 56. By Type, Europe Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 58. China Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, China Lacosamide Tablets Market Share, 2022
Figure 60. By Type, China Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, Japan Lacosamide Tablets Market Share, 2022
Figure 64. By Type, Japan Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, South Korea Lacosamide Tablets Market Share, 2022
Figure 68. By Type, South Korea Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, Southeast Asia Lacosamide Tablets Market Share, 2022
Figure 72. By Type, Southeast Asia Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 74. India Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 75. By Company, India Lacosamide Tablets Market Share, 2022
Figure 76. By Type, India Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Lacosamide Tablets Sales Volume, 2018-2029, (K Units)
Figure 79. By Company, Middle East & Asia Lacosamide Tablets Market Share, 2022
Figure 80. By Type, Middle East & Asia Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Lacosamide Tablets Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|